“Researchers began a randomized, controlled trial of the antiviral in February 2020 to test whether remdesivir could be used to treat SARS-CoV-2, the coronavirus that causes COVID-19. By April, early results indicated that remdesivir accelerated recovery for hospitalized patients with severe COVID-19. It became the first drug to receive emergency use authorization from the U.S. Food and Drug Administration (FDA) to treat people hospitalized with COVID-19.
Researchers have now completed the trial, known as the Adaptive COVID-19 Treatment Trial (ACTT-1). The study was funded by the National Institute of Allergy and Infectious Diseases (NIAID). The final report appeared in the New England Journal of Medicine on October 8, 2020.”
The results? Treatment with Remdesivir reduced hospitalization by about 1/3, lessened the seriousness of the disease, and reduced mortality. However, most interesting about this article is what it left out. President Trump was treated with it and went on TV praising the drug. He should be the poster child for its effectiveness. However, the article which appears in NIH Research Matters, doesn’t mention his incredibly fast recover and return to his old energetic self as he outcampaign Biden about 10 to 1. Rudy also took Remdesivir during his recent, brief treatment.
Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH)
Posts
No comments:
Post a Comment